ZHEJIANG DOER BIOLOGICS CORP has a total of 19 patent applications. It increased the IP activity by 20.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are UNUM THERAPEUTICS, DIACCURATE and BOGOCH SAMUEL.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | China | 8 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Fermentation | |
#6 | Enzymes | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Huang Yanshan | 19 |
#2 | Wen Xiaofang | 5 |
#3 | Yao Gaofeng | 5 |
#4 | Chen Yonglu | 4 |
#5 | Dong Jiali | 4 |
#6 | Fang Yilin | 3 |
#7 | Li Changkui | 3 |
#8 | Yang Zhiyu | 3 |
#9 | Zhou Zhenxing | 3 |
#10 | Zhang Hongta | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021031716A1 | Anti-pd-l1 single domain antibodies | |
CN111087478A | Recombinant collagen and preparation method thereof | |
CN111944055A | Fusion protein for treating metabolic diseases | |
CN111434692A | anti-C L D18A2 nano antibody and application thereof | |
CN111153965A | Artificial recombinant protein for improving performance of active protein or polypeptide and application thereof | |
CN111040021A | Carrier protein for improving properties of bioactive protein | |
CN109836488A | A kind of glucagon analogue for treating metabolic disease | |
CN109836503A | A kind of multiple activities albumen for treating metabolic disease | |
CN109836504A | A kind of Multidomain activated protein for treating metabolic disease | |
US2019241639A1 | Fusion protein for treating intestinal diseases |